SPRINGFIELD - There aren't very many businesses that can say they've been around since the horse-and-buggy days. In fact, the reference is usually a punch line at the end of a derisive joke about old ...
On Thursday, Spring Works Therapeutics (NASDAQ:SWTX) maintained a positive outlook from market analysts following a reiteration of a Buy rating and a $63 stock price target. The focus is on the ...
Goldman Sachs has reaffirmed its Buy rating on Spring Works Therapeutics (NASDAQ: SWTX), with a steady price target of $60.00. The decision follows recent developments regarding the company's new drug ...
Stories by Amor Towles, a sequel to Colm Toibin’s “Brooklyn,” a new thriller by Tana French and more. By Kate Dwyer March In her second novel, Gonzalez, a Pulitzer Prize finalist and the author of ...
If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. From now until March 6th, it’s time to stock up! Single-wick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback